National Vaccine Program
Office is developing a list of "private sector vaccine developers with whom it will routinely communicate," NVPO announces in Aug. 8 Federal Register. "All private sector entities engaged in the development of vaccines against infectious diseases" are encouraged to contact Roy Widdus, National Vaccine Program Office, 5600 Fishers Lane, Rockwall II Building, Suite 1075, Rockville, Md., 20857
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth